“…Nrf2 is an important transcriptional factor involved in the activation of ARE-mediated phase-II gene induction, and results from our previous study revealed that the hepatic expression of Nrf2 mRNA only had a moderate increase (73%) in mice on the atherogenic diet compared to AIN-93M purified diet (Guo et al , 2015b), however, it was reported that the activation of Nrf2 is mainly due to posttranscriptional modification and translocation to the nucleus (Mota et al , 2015; Rushmore and Kong, 2002). Many phase-II enzymes are induced with graded Nrf2 activation though decreased Kelch-like ECH associating protein 1 expression (Wu et al , 2012) and Nrf2 activators (Alnouti and Klaassen, 2008), and in the current study some of the Nrf2 target genes including Ugt2b35, 2b36, Sult1b1, Gsts (Gsta2, a4, m1, m2, m3, m6, p1, t3 and mGst3) and Ugdh were up-regulated in livers of mice fed the restricted diet, moreover, among those phase-II genes, Gstm3 that was increased the most by graded Nrf2 activation (Wu et al , 2012) also had the largest fold changes by diet-restriction, which indicates the role that Nrf2 might play in the restricted diet.…”